News | December 19, 2025
Ambros Therapeutics launches with $125 million to advance breakthrough therapy for rare pain disorder
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing
The PIPE offering consists of 36,190,476 units
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
Subscribe To Our Newsletter & Stay Updated
